Literature DB >> 2357784

Use of spironolactone in treatment of hirsutism.

D C Cumming1.   

Abstract

Spironolactone (Aldactone), 100 mg to 200 mg daily, has antiandrogenic effects that may enhance treatment of androgen-excess syndromes, particularly severe hirsutism. Combination therapy with an oral contraceptive or with dexamethasone appears to have a beneficial effect. Side effects are transient. The drug should be avoided during pregnancy and in women who have a family history of breast cancer, although there is no proven association between spironolactone and breast malignancy.

Entities:  

Keywords:  Androgens; Biology; Clinical Research; Contraception; Contraceptive Methods--therapeutic use; Diseases; Drugs--administraction and dosage; Endocrine System; Family Planning; Hirsutism--prevention and control; Hormones; Oral Contraceptives--therapeutic use; Physiology; Research Methodology; Signs And Symptoms; Testosterone; Treatment

Mesh:

Substances:

Year:  1990        PMID: 2357784     DOI: 10.3949/ccjm.57.3.285

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  3 in total

1.  [Spironolactone in dermatological treatment. On and off label indications].

Authors:  C M Salavastru; K Fritz; G S Tiplica
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

Review 2.  Approach to patients with hirsutism.

Authors:  R Sakiyama
Journal:  West J Med       Date:  1996-12

3.  Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction.

Authors:  Søren Ulrik Salling Sønder; Marianne Mikkelsen; Klaus Rieneck; Chris Juul Hedegaard; Klaus Bendtzen
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.